Devyser Diagnostics AB (publ) (STO: DVYSR)
Sweden
· Delayed Price · Currency is SEK 133.00
+1.00 (0.76%)
Nov 20, 2024, 5:29 PM CET
Devyser Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 198.1 | 169.3 | 126.6 | 93.48 | 65.69 | 64.3 | Upgrade
|
| Revenue Growth (YoY) | 25.30% | 33.73% | 35.43% | 42.31% | 2.16% | 33.55% | Upgrade
|
| Cost of Revenue | 39.6 | 24.5 | 23.2 | 21.57 | 18.67 | 15.16 | Upgrade
|
| Gross Profit | 158.5 | 144.8 | 103.4 | 71.91 | 47.02 | 49.14 | Upgrade
|
| Selling, General & Admin | 187.3 | 163.5 | 132.1 | 75.65 | 41.9 | 33.73 | Upgrade
|
| Research & Development | 45 | 37.8 | 26.3 | 18.07 | 16.68 | 6.76 | Upgrade
|
| Other Operating Expenses | -0.3 | -0.3 | -0.2 | -0.12 | -2.38 | -1.89 | Upgrade
|
| Operating Expenses | 232 | 201 | 158.2 | 93.6 | 56.21 | 38.61 | Upgrade
|
| Operating Income | -73.5 | -56.2 | -54.8 | -21.69 | -9.19 | 10.53 | Upgrade
|
| Interest Expense | -2.6 | -0.8 | -0.5 | -0.94 | -0.93 | -0.79 | Upgrade
|
| Interest & Investment Income | 6.6 | 5 | 0.3 | 0.01 | 0 | - | Upgrade
|
| Earnings From Equity Investments | - | - | - | 0.37 | -1.04 | -0.52 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.6 | -2.3 | 1.2 | 0.06 | -0.74 | 0.41 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.1 | - | - | 0.22 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -73 | -54.3 | -53.8 | -21.97 | -11.9 | 9.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 1.6 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.4 | -0.4 | 0.1 | 0.07 | - | - | Upgrade
|
| Asset Writedown | 0.3 | 0.3 | -0.7 | -0 | - | - | Upgrade
|
| Pretax Income | -73.1 | -54.4 | -52.8 | -21.91 | -11.9 | 9.63 | Upgrade
|
| Income Tax Expense | -1.7 | -0.8 | -6.8 | -1.18 | -0.99 | 2.62 | Upgrade
|
| Net Income | -71.4 | -53.6 | -46 | -20.73 | -10.91 | 7.01 | Upgrade
|
| Net Income to Common | -71.4 | -53.6 | -46 | -20.73 | -10.91 | 7.01 | Upgrade
|
| Net Income Growth | - | - | - | - | - | 1250.48% | Upgrade
|
| Shares Outstanding (Basic) | 16 | 16 | 16 | 11 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 16 | 16 | 11 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | 1.40% | 1.63% | 41.78% | 28.98% | -4.34% | 1.04% | Upgrade
|
| EPS (Basic) | -4.37 | -3.31 | -2.89 | -1.85 | -1.25 | 0.81 | Upgrade
|
| EPS (Diluted) | -4.37 | -3.31 | -2.89 | -1.85 | -1.25 | 0.77 | Upgrade
|
| EPS Growth | - | - | - | - | - | 1237.00% | Upgrade
|
| Free Cash Flow | -85.3 | -81.2 | -48.4 | -18.68 | 0.55 | 14 | Upgrade
|
| Free Cash Flow Per Share | -5.22 | -5.02 | -3.04 | -1.66 | 0.06 | 1.54 | Upgrade
|
| Gross Margin | 80.01% | 85.53% | 81.67% | 76.93% | 71.58% | 76.42% | Upgrade
|
| Operating Margin | -37.10% | -33.20% | -43.29% | -23.20% | -13.99% | 16.38% | Upgrade
|
| Profit Margin | -36.04% | -31.66% | -36.33% | -22.17% | -16.61% | 10.90% | Upgrade
|
| Free Cash Flow Margin | -43.06% | -47.96% | -38.23% | -19.98% | 0.84% | 21.77% | Upgrade
|
| EBITDA | -59.9 | -52.5 | -52.6 | -20.99 | -8.63 | 11.1 | Upgrade
|
| EBITDA Margin | -30.24% | -31.01% | -41.55% | -22.46% | -13.13% | 17.26% | Upgrade
|
| D&A For EBITDA | 13.6 | 3.7 | 2.2 | 0.69 | 0.57 | 0.56 | Upgrade
|
| EBIT | -73.5 | -56.2 | -54.8 | -21.69 | -9.19 | 10.53 | Upgrade
|
| EBIT Margin | -37.10% | -33.20% | -43.29% | -23.20% | -13.99% | 16.38% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 27.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.